T. Miyamoto

A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer

Norikazu Masuda, Kenji Higaki, Toshimi Takano et al. · Cancer Chemotherapy and Pharmacology · 2014 · 38 citations

Medicine, Oncology, Pharmacology +16

Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer

M. Murakami, T. Miyamoto, Takuto IIDA et al. · International Journal of Gynecological Cancer · 2006 · 21 citations

Medicine, Nuclear Medicine, Oncology +17

EMMPRIN (CD147) expression and differentiation of papillary thyroid carcinoma: implications for immunocytochemistry in FNA cytology

Yatsuki Aratake, Kosuke Marutsuka, Kazuaki Kiyoyama et al. · Cytopathology · 2009 · 12 citations

Medicine, Oncology, Pathology +17